Following its ambitious effort to rapidly build six hand sanitizer plants during the early months of the COVID-19 pandemic, British chemicals firm INEOS is introducing a new consumer healthcare-focused business, INEOS Hygienics, the company announced in a release Thursday.

“The launch of INEOS Hygienics is another step forward in the fight against COVID-19. The world will look at daily hygiene differently going forward and many people are still struggling to buy medical grade gels and cleaners,” said George Ratcliffe, chief operating officer of the newly-created business, in a statement. “INEOS produce the highest quality ethanol, we are well placed to offer a solution to this new world outlook.”

INEOS Hygienics will manufacture hospital-grade hand gels, sanitizer sprays for hands and surfaces, and sanitizer wipes for retail sale to the public. Production will take place at plants in Newton Aycliffe in the UK, Neville Island, PA, Jacksonville, FL, Etain, France, and Herne, Germany.

“To date, we’ve delivered more than four million bottles of sanitizer to hospitals around the world, bringing confidence to thousands of frontline medical staff and care providers,” Ratcliffe said. “Now, we’re able to offer that same level of protection to the public. INEOS sanitizer products will now help us all to target viruses and bacteria with confidence at home, at work and beyond.”

The company is Europe’s largest producer of isopropyl alcohol (IPA) and ultra-high-purity ethanol, which are used as main ingredients in sanitizer products.

Sanitizers made by INEOS Hygienics will be sold in supermarkets, pharmacies, wholesalers, and Amazon.com in the US, France, Germany, and the UK.